tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

IMVT Stock Latest News

Immunovant’s Strategic Advancements and Targeted Approach Drive Buy Rating
RatingsImmunovant’s Strategic Advancements and Targeted Approach Drive Buy Rating
3h ago
IMVT
Immunovant Announces New CEO Amid Strategic Shift
PremiumCompany Announcements
Immunovant Announces New CEO Amid Strategic Shift
12h ago
8K
IMVT
Immunovant appoints Eric Venker as CEO, Girao as CFO
PremiumThe Fly
Immunovant appoints Eric Venker as CEO, Girao as CFO
12h ago
IMVT
ROIV
Insider Moves: Cytokinetics, Bj’s, Gran Tierra, PBF, Immunovant
PremiumWeekend Updates
Insider Moves: Cytokinetics, Bj’s, Gran Tierra, PBF, Immunovant
2d ago
BJ
GTE
Immunovant’s Competitive Edge and Growth Potential: Buy Rating Supported by IMVT-1402 Approval and Promising Study Results
PremiumRatings
Immunovant’s Competitive Edge and Growth Potential: Buy Rating Supported by IMVT-1402 Approval and Promising Study Results
10d ago
IMVT
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
1M ago
INO
ARCT
Buy Rating Affirmed for IMVT-1402: Promising Study Results and Strategic Focus in FcRn Space
Premium
Ratings
Buy Rating Affirmed for IMVT-1402: Promising Study Results and Strategic Focus in FcRn Space
1M ago
IMVT
Immunovant price target raised to $61 from $58 at Stifel
Premium
The Fly
Immunovant price target raised to $61 from $58 at Stifel
1M ago
IMVT
Immunovant price target lowered to $33 from $38 at BofA
PremiumThe Fly
Immunovant price target lowered to $33 from $38 at BofA
1M ago
IMVT
Immunovant data positive for Biohaven, says Deutsche Bank
PremiumThe Fly
Immunovant data positive for Biohaven, says Deutsche Bank
1M ago
BHVN
IMVT
Immunovant’s Promising Clinical Trial Results and Market Dynamics Drive Buy Rating
PremiumRatings
Immunovant’s Promising Clinical Trial Results and Market Dynamics Drive Buy Rating
1M ago
IMVT
Immunovant’s Batoclimab Shows Promising Efficacy in MG and CIDP, Justifying Buy Rating
PremiumRatings
Immunovant’s Batoclimab Shows Promising Efficacy in MG and CIDP, Justifying Buy Rating
1M ago
IMVT
Immunovant’s batoclimab shows ‘impressive’ efficacy in MG, says H.C. Wainwright
PremiumThe FlyImmunovant’s batoclimab shows ‘impressive’ efficacy in MG, says H.C. Wainwright
1M ago
IMVT
Immunovant Announces Positive Phase 3 Study Results
Premium
Company Announcements
Immunovant Announces Positive Phase 3 Study Results
1M ago
8K
IMVT
Immunovant announces results from Phase 3 study of batoclimab in MG
Premium
The Fly
Immunovant announces results from Phase 3 study of batoclimab in MG
1M ago
IMVT
Roivant says Immunovant announces results from Phase 3 study of batoclimab in MG
PremiumThe Fly
Roivant says Immunovant announces results from Phase 3 study of batoclimab in MG
1M ago
IMVT
ROIV
Immunovant’s Phase 3 Trial of Batoclimab: A Catalyst for Future Growth and Market Impact
PremiumRatings
Immunovant’s Phase 3 Trial of Batoclimab: A Catalyst for Future Growth and Market Impact
1M ago
IMVT
Biohaven price target lowered to $57 from $73 at Bernstein
PremiumThe Fly
Biohaven price target lowered to $57 from $73 at Bernstein
2M ago
BHVN
IMVT
Immunovant initiated with a Hold at Jefferies
PremiumThe Fly
Immunovant initiated with a Hold at Jefferies
2M ago
IMVT
Immunovant’s Promising Pipeline and Strategic Focus Drive Buy Rating
PremiumRatingsImmunovant’s Promising Pipeline and Strategic Focus Drive Buy Rating
2M ago
IMVT
Immunovant’s Promising Outlook: Buy Rating on Phase 3 Batoclimab Data and Strategic Differentiation
Premium
Ratings
Immunovant’s Promising Outlook: Buy Rating on Phase 3 Batoclimab Data and Strategic Differentiation
2M ago
IMVT
Roivant Sciences price target lowered to $12 from $13 at BofA
Premium
The Fly
Roivant Sciences price target lowered to $12 from $13 at BofA
2M ago
IMVT
ROIV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >